The Pharmacy Benefit Management Institute (PBMI) recently held its annual conference. This year, the hybrid format allowed for lively discussions on specialty drug costs, the use of biologics in rare disease, data interoperability strategies, and the impact of the COVID-19 pandemic.
“Data is king in managing drug costs and healthcare overall. But it tends to be walled off into small, tightly controlled fiefs, so getting a full picture, going by the numbers, is nigh impossible… Fredell, at CVS, spoke about the importance of “connectivity” and the information coming from the electronic health records and from patients.” Read more here.
(Source: Peter Wehrwein, Managed Healthcare Executive, 9/17/21)